Written by
Science & Humans
1-877-286-6635
Written by
Science & Humans
Medically approved by
Maria Jacob
Last updated
11/21/2024 5:30:00 AM
Share
Semaglutide is the active ingredient of both Ozempic, a diabetes drug and Wegovy, a weight loss drug, regulated by the US FDA. It works by secreting more glucose-dependent insulin from the pancreas, as well as delaying gastric emptying and prolonging satiety, helping in reducing weight.
Semaglutide as Ozempic has a different dosing schedule as compared to Wegovy, which has a higher dose. Clinical studies have shed light on the safety and efficacy of both these drugs.
However, these drugs should be only taken as prescribed by the consulting physician. Self-medication is injudicious. For people looking solely for a weight loss drug Ozempic may not be the best choice since it has a different dosing to show significant weight loss results. For people with type 2 diabetes using Ozempic weight loss is another benefit which they may or may not experience. To get optimal weight loss benefits depending on a patient’s weight (overweight or obese) Wegovy is the choice of drug.
Ozempic, chemically known by its active ingredient Semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist or analogue secreted by the L-cells of the pancreas. This means that it is a synthetic form of GLP-1 which makes the islet cells in the pancreas secrete more glucose-dependent insulin whenever one eats anything and simultaneously increases glucose uptake by muscles.(1) (2) It also acts by slowing the release of glucagon from the pancreas. GLP-1 agonists when taken in higher amounts also delay gastric emptying, induce a feeling of satiety, and reduce the appetite. Ozempic is also known for its cardioprotective and neuroprotective effects.(1)
Semaglutide is primarily known to be a type 2 diabetes drug Ozempic, used as a once-daily injectable medicine to keep blood sugar levels under check. However, Semaglutide, the main active ingredient in Ozempic has also been regulated to be taken in high doses by the US FDA under the brand name Wegovy.
Ozempic has been declared as an overall safe medication post clinical trials. However, like every other medicine, Ozempic side effects have also been reported in some patient populations. Hypoglycemia, diarrhoea, nausea, constipation, gas reflux, and flatulence are the most reported Wegovy and Ozempic side effects. However, semaglutide side effects resolve on their own within a few weeks.(3)
Severe semaglutide side effects include worsening of diabetic retinopathy in patients who are already on insulin and taking Ozempic. People with severe allergies should avoid taking Ozempic. For patients on Wegovy, there are risks of thyroid C-cell tumors, and hence patients with a medical history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should be extra cautious if advised to take Wegivy. Wegovy side effects can be severe for patients with a history of pancreatitis, gallstones, acute kidney injury, increased heartbeat, suicidal tendencies, or hypotension. (7) (8)
Semaglutide, when taken as a prescription medicine for type 2 diabetes, is an Ozempic injection. The Ozempic injection is given as a 0.25 mg once a week dose for the first four weeks, and increased to 0.5 mg once a week from the fifth week. Depending on individual cases, the doctor may also increase dosage to 1 mg. These doses are delivered best with a 0.25mg or 0.5mg Ozempic injection pen with a strength of 2 mg per 1.5 mL of liquid solution. The maximum dosage is 2mg per week.(7) Ozempic injection pens come with strengths of 1mg and 2mg used for additional control. The strengths of these syringes are 4 mg/3 mL of liquid solution and 8 mg/3 mL of liquid solution respectively. The 1mg syringe should be used once weekly for four weeks for additional glucose control and the 2mg syringe should be used once weekly if the doctor asks for further control post the initial monitoring process. (7) (9)
Semaglutide when taken as Wegovy, is recommended at higher doses for people fighting obesity, defined as having a BMI ≥30 kg/m2, or are overweight with a BMI ≥27 kg/m2 in the presence of a weight-related comorbidity, and for obese children over 12 years of age and older with an initial BMI at ≥95th percentile standardized for age and sex.(10) Wegovy dosing is also recommended initially as 0.25mg for the first four weeks, with an escalation to 0.5mg per week from the fifth to the eighth week. Further escalation when prescribed for additional control ranges from 1mg each week from the ninth to the twelfth week to 1.7mg once weekly from the thirteenth till the sixteenth week. Many cases will require the patient to stick to this dosage. If the target weight is still not reached, a further escalation to 2.4mg per week from the seventeenth week onwards till however long the doctor prescribes, as per the patient’s health and weight goals.(10)
It is imperative to understand that the dosing should only be modified under expert, professional opinion backed by laboratory test results.
Ozempic pricing can be on the higher side, ~ $1000 for a supply of 1.5mL. Hence it is also important to use the drug judiciously and be informed about insurance coverage whenever applicable.(11)
In the Ozempic dosing schedule, the patient should stick to the same day for injecting the doses on all weeks. e.g. If the patient is taking the dose on a Tuesday on the first week of dosing, they should continue taking the doses on all the following Tuesdays for the entire duration. However, if the patient misses one dose and remembers this within five days of the scheduled dose, they can take it immediately within those five days. In case they do not remember to take the missed dose within these five days, they should just continue with the next dose and forget about the last dose missed. There is absolutely no need to make up for a missed dose by taking an extra dose. (7) (9) Patients should not stop using Ozempic in between doses and should stick to the dosing schedule, unless and until advised otherwise by the doctor or consulting specialist.
Ozempic dosing when done in excess can lead to consequences like nausea, vomiting and diarrhoea apart from other complications due to comorbidities. Patients are advised to contact the nearest emergency center in need of medical attention.
Semaglutide when taken as Wegovy should also be taken on the same day of the week after starting dosing. In case a patient forgets to take a dose and remembers it within the next 48 hours, they should take the missed dose immediately. In case it has been more than 48 hours since the patient has missed a dose, they should continue with the next dose as per schedule and not take an extra dose to make up for the missed dose. In case two or more doses are missed by the patient consecutively, they should just continue with the dosing as scheduled. In this case, however, the patient can restart the dosing at the escalated schedule after consulting a doctor. They may face gastrointestinal symptoms which subside on their own after a few weeks of the escalated schedule.(10) In any case, patients should always have an emergency number at their disposal for immediate medical attention.
Patients taking sulfonylurea (glimepiride or glibenclamide), and/or insulin should not take Ozempic or Wegovy; if they need to, they should do so only if prescribed by the doctor under full cognizance of the other oral medications the patient is on. Ozempic or Wegovy dosing and escalations will depend on the other medications that the patient is on.
Pregnant women are not advised to take semaglutide, and if planning to get pregnant, should stop using semaglutide at least two months prior to conceiving. Patients with ketoacidosis or/and type 1 diabetes should also avoid taking semaglutide or take only if recommended by endocrinologists.
Both drugs are forms of Semaglutide but function at different concentrations. The US FDA has regulated the use of semaglutide for weight loss as Wegovy and semaglutide for type 2 diabetes as Ozempic. Despite having the same active ingredient, both medications have different dosing schedules which patients should stick to. For people taking Ozempic weight loss can be another benefit, but Ozempic is primarily prescribed for type 2 diabetes and should not be mistaken as a weight loss drug.
Semaglutide and weight loss have been studied extensively and have shown beneficial results but patients should not self-medicate with Ozempic off-label just because the active ingredient is regulated for weight loss. There is a reason why both drugs have different dosing and one should have a clear prescription for using any drug. Compounding both forms of semaglutide for weight loss is not regulated by the US FDA due to adverse events reported by patients.(12)
Ozempic is a diabetes drug regulated by the US FDA. It has the active ingredient called semaglutide which is also the active ingredient for the drug Wegovy, which is regulated by the FDA for weight loss albeit at a higher dose. Ozempic dosage does not equal to Wegovy dosage. Use a prescribed drug for your condition; do not self-medicate with any drug just because they have the same active ingredient.
Semaglutide is the active ingredient of both the diabetes drug Ozempic and the weight loss drug Wegovy. Ozempic and Wegovy are regulated for use in different doses for both conditions. The chemical nature of semaglutide is such that it keeps glucose levels in check as well as ensures a calorie deficit by reducing the appetite and keeping a patient feeling fuller for longer due to delayed gastric emptying. Wegovy and Ozempic have different dosing.
Pharmacies compound drugs to make up for shortages. However, there have been many adverse effects reported by the US FDA from cases of compounded Ozempic and Wegovy use and this process of drug compounding is not regulated by the US FDA. Use Ozempic/Wegovy only after you get a doctor’s prescription clearly mentioning the specific doses to be taken.
References
|
© 2022 Science & Humans. All Rights Reserved.